Literature DB >> 11117778

Splenic marginal zone lymphoma with or without plasmacytic differentiation.

J P Duong Van Huyen1, T Molina, A Delmer, J Audouin, A Le Tourneau, R Zittoun, A Bernadou, J Diebold.   

Abstract

We report a series of 31 cases of splenic marginal zone lymphomas with an enlarged spleen and a multimicronodular macroscopic pattern. Two groups, A and B, were distinguished based on the presence (A) or absence (B) of a lymphoplasmacytic component with monoclonal immunoglobulin expression in the cytoplasm. There were no differences between the groups as far as age, sex, spleen weight, and progression. The only difference was the presence in group A of a monoclonal serum component and autoimmune disorders, particularly autoimmune hemolytic anemia. In most cases in which a liver and/or bone marrow biopsy was performed, lymphomatous infiltration was detected. Seven cases had a seric monoclonal IgM of 5 g/L or more and liver or bone marrow infiltration, corresponding to the definition of Waldenstrom's macroglobulinemia. Lymphoma cells had a monocytoid, centrocytoid and, in group A, lymphoplasmacytic morphology. The lymphomatous cells were positive for CD20, CD45 RA, and bcl-2. They expressed IgD in 9 cases, partially in 6, and were negative for IgD in 9 of the 24 cases studied. Progression seems to be slow, with a long survival. Three patients presented with transformation into a large B-cell lymphoma, which was responsible for death in two patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11117778     DOI: 10.1097/00000478-200012000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

1.  Splenic marginal zone lymphomas appear to originate from different B cell types.

Authors:  David W Bahler; J Ander Pindzola; Steven H Swerdlow
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

2.  Splenic marginal zone lymphoma: hydra with many heads?

Authors:  Luca Arcaini; Marco Paulli
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

3.  Marginal zone lymphoma of both spleen and kidney displaying transformation into large B-cell lymphoma.

Authors:  A Canelhas; E Compérat; A Le Tourneau; T Molina; M Ramos; P Ribeiro; A Pimenta; J Diebold; J Audouin
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

4.  CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.

Authors:  Lucile Baseggio; Alexandra Traverse-Glehen; Florence Petinataud; Evelyne Callet-Bauchu; Françoise Berger; Martine Ffrench; Chantal Marie Couris; Catherine Thieblemont; Dominique Morel; Bertrand Coiffier; Gilles Salles; Pascale Felman
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

5.  Primary splenic diffuse large B-cell lymphoma manifesting in red pulp.

Authors:  Makoto Kashimura; Masahiro Noro; Bunshiro Akikusa; Atsushi Okuhara; Shuji Momose; Ikuo Miura; Masaru Kojima; Jun-Ichi Tamaru
Journal:  Virchows Arch       Date:  2008-09-26       Impact factor: 4.064

6.  TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation.

Authors:  Jennifer Shrimpton; Matthew A Care; Jonathan Carmichael; Kieran Walker; Paul Evans; Charlotte Evans; Ruth de Tute; Roger Owen; Reuben M Tooze; Gina M Doody
Journal:  Blood Adv       Date:  2020-06-23

7.  Defining the borders of splenic marginal zone lymphoma: a multiparameter study.

Authors:  Scott D Dufresne; Raymond E Felgar; Rachel L Sargent; Urvashi Surti; Susanne M Gollin; Ellen D McPhail; James R Cook; Steven H Swerdlow
Journal:  Hum Pathol       Date:  2009-12-11       Impact factor: 3.466

8.  [Lymphomas of the spleen].

Authors:  A Marx; H K Müller-Hermelink; M Hartmann; E Geissinger; A Zettl; P Adam; T Rüdiger
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

9.  No V(H) somatic hypermutation was detected in B-cells of a patient with macroglobulinemia due to splenic marginal zone lymphoma.

Authors:  Tetsuaki Sekikawa; Shinobu Takahara; Takeshi Kawano; Shuji Nakada; Kiyoshi Ito; Satsuki Iwase; Hisashi Yamada; Masayuki Kobayashi; Junko Horiguchi-Yamada
Journal:  Int J Hematol       Date:  2002-12       Impact factor: 2.490

10.  MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Authors:  Fatima Hamadeh; Stephen P MacNamara; Nadine S Aguilera; Steven H Swerdlow; James R Cook
Journal:  Mod Pathol       Date:  2014-09-12       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.